Advanced search
Publication Cover
Scandinavian Journal of Urology Volume 57, 2023 - Issue 1-6
Journal homepage
3,526
Views
0
CrossRef citations to date
0
Altmetric
Articles

Salvage HDR brachytherapy for prostate cancer: a high-volume center experience on 100 consecutive patients

Lauri Mäkeläa Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandCorrespondence[email protected]
View further author information
,
Robin Bergrothb Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
,
Lauri Taipaleb Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
,
Sara Tornbergb Department of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
&
Harri Visapääa Comprehensive Cancer Center, University of Helsinki and Helsinki University Hospital, Helsinki, FinlandView further author information
Pages 36-40 | Received 09 May 2022, Accepted 09 Jan 2023, Published online: 01 Feb 2023

References

  • Zumsteg ZS, Spratt DE, Romesser PB, et al. The natural history and predictors of outcome Following biochemical relapse in the dose escalation era for prostate cancer patients undergoing definitive external beam radiotherapy. Eur Urol. 2015;67(6):1009–1016.
  • Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer. Part II-2020 update: treatment of relapsing and metastatic prostate cancer. Eur Urol. 2021;79(2):263–282.
  • Uchida T, Shoji S, Nakano M, et al. High-intensity focused ultrasound as salvage therapy for patients with recurrent prostate cancer after external beam radiation, brachytherapy or proton therapy. BJU Int. 2011;107(3):378–382.
  • Henríquez López I, González-San Segundo C, Vegas JO, et al. Salvage brachytherapy for locally-recurrent prostate cancer after radiation therapy: a comparison of efficacy and toxicity outcomes with high-dose rate and low-dose rate brachytherapy. Radiother Oncol. 2019;141:156–163.
  • Łyczek J, Kawczyńska MM, Garmol D, et al. HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer. J Contemp Brachytherapy. 2009;1(2):105–108.
  • Wojcieszek P, Szlag M, Głowacki G, et al. Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure. Radiother Oncol. 2016;119(3):405–410.
  • Chen CP, Weinberg V, Shinohara K, et al. Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes. Int J Radiat Oncol Biol Phys. 2013;86(2):324–329.
  • Wu SY, Wong AC, Shinohara K, et al. Salvage high-dose-rate brachytherapy for recurrent prostate cancer after definitive radiation. Pract Radiat Oncol. 2021;11(6):515–526.
  • Valle LF, Lehrer EJ, Markovic D, et al. A systematic review and meta-analysis of local salvage therapies after radiotherapy for prostate cancer (MASTER). Eur Urol. 2021;80:280–292.
  • Rouvière O, Vitry T, Lyonnet D. Imaging of prostate cancer local recurrences: why and how? Eur Radiol. 2010;20(5):1254–1266.
  • Perera M, Papa N, Christidis D, et al. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;70:926–937.
  • Evans AJ. Treatment effects in prostate cancer. Mod Pathol. 2018;31:110–121.
  • Goldstein NS, Martinez A, Vicini F, et al. The histology of radiation therapy effect on prostate adenocarcinoma as assessed by needle biopsy after brachytherapy boost: correlation With biochemical failure. Am J Clin Pathol. 1998;110(6):765–775.
  • Corkum MT, Mendez LC, Chin J, et al. A novel salvage option for local failure in prostate cancer, reirradiation using external beam or stereotactic radiation therapy, systematic review and meta-analysis. Adv Radiat Oncol. 2020;5:965–977.
  • Jereczek-Fossa BA, Marvaso G, Zaffaroni M, on Behalf of the European Society for Radiotherapy, Oncology Advisory Committee on Radiation Oncology Practice (ESTRO ACROP), et al. Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: an ESTRO ACROP delphi consensus. Cancer Treat Rev. 2021;98:102206.
  • Andriole GL, Kostakoglu L, Chau A, et al. The impact of positron emission tomography with 18F-Fluciclovine on the treatment of biochemical recurrence of prostate cancer. Results from the LOCATE Trial. J Urol. 2019;201:322–331.
  • Scarsbrook AF, Bottomley D, Teoh EJ, et al. Effect of 18F-fluciclovine positron emission tomography on the management of patients with recurrence of prostate cancer: results from the Falcon Trial. Int J Radiat Oncol Biol Phys. 2020;107:316–324.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.